Submit Deal

SCILEX HOLDING COMPANY

HQ - Palo Alto, CA

Summary

Scilex Holding Company is a pharmaceutical company focused on the acquisition, development, and commercialization of non-opioid pain management products

Deals Overview

Total Deals3

Valued Deals3

Total Value£ 3.52 B

Avg. Deal Size£ 1.17 B

Market Context

Senior Management

Henry Ji
Chairman and CEO

Sort

17 Mar 2022|United States|Biotechnology

Target: SCILEX HOLDING COMPANY

Bidder: VICKERS VANTAGE CORP I

5 Service Providers

2 Target | 2 Bidder | 1 Vendor

4 Dealmakers

2 Target | 1 Bidder | 1 Vendor

£ 1.44 B

Value

02 Jul 2024|United States|Pharmaceuticals

Target: SEMNUR PHARMACEUTICALS INC

Bidder: DENALI CAPITAL ACQUISITION CORP

5 Service Providers

2 Target | 2 Bidder | 1 Vendor

24 Dealmakers

10 Target | 14 Bidder | 1 Vendor

£ 1.97 B

Value

25 Sep 2025|United States|Data Centers and Hosting

Target: DATAVAULT AI INC

Bidder: SCILEX HOLDING COMPANY

4 Service Providers

2 Target | 2 Bidder

8 Dealmakers

1 Target | 7 Bidder

£ 111 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy